Aldosterone status associated with insulin resistance in patients with heart failure—data from the ALOFT study

E. Marie Freel; Ioannis Tsorlalis; Jim Lewsey; Roberto Latini; Aldo Maggioni; Scott Solomon; B. Pitt; J M C Connell; John J.V. McMurray

doi:10.1136/hrt.2009.173344

Related publications

Article2010

Renin Inhibitors in Chronic Heart Failure: The Aliskiren Observation of Heart Failure Treatment Study in Context

Henry Krum, Aldo Maggioni

Article2007

Abstract 2491: Neurohumoral Effects Of A New Oral Direct Renin Inhibitor In Stable Heart Failure: The Aliskiren Observation Of Heart Failure Treatment Study (ALOFT).

Bertram Pitt, John J.V. McMurray, Roberto Latini, Aldo Maggioni, Scott D. Solomon, Beverly A. Smith, Christopher Bush, Margaret F. Prescott

Article2023

Rate of Kidney Function Decline is Associated With Kidney and Heart Failure in Individuals With Type 1 Diabetes

Niina Sandholm, Erkka Valo, Jaakko Tuomilehto, Valma Harjutsalo, Per‐Henrik Groop

Kidney International Reports

Article2005

[The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design].

Giuseppe Cacciatore, Alessandro Boccanelli, Gian Francesco Mureddu, Aldo Maggioni, Roberto Latini, Serge Masson, Giovanni de Simone

Article2023

Heart Failure Patients with Improved Ejection Fraction: Insights from the MECKI Score Database

Piergiuseppe Agostoni, Francesca Pluchinotta, Elisabetta Salvioni, Massimo Mapelli, Arianna Galotta, Alice Bonomi, Damiano Magrì, Enrico Perna, Stefania Paolillo, Ugo Corrà, Rosa Raimondo, Rocco Lagioia, Roberto Badagliacca, Pasquale Perrone Filardi, Anna Apostolo, Michele Senni, Alfonso Iorio, Michele Correale, Jeness Campodonico, Pietro Palermo, Mariantonietta Cicoira, Marco Metra, Marco Guazzi, Giuseppe Limongelli,